Pharmamarketeer

Evofem announces additional data from phase 3 ‘AMPOWER’ study of Amphora for hormone─free birth control

Evofem Biosciences, a clinical─stage biopharmaceutical company, reported additional data from its phase 3 ‘AMPOWER’ clinical trial of Amphora for the prevention of pregnancy. These findings reveal that the

Advertentie(s)
Geen nieuws missen?
Volg de duizenden farma professionals die Pharmamarkteer.nl via e-mail lezen

Uw inschrijving is gelukt.
Bedankt!
Naar Pharmamarkteer.nl